Jie Tang

4PUBLICATIONS
26CO-AUTHORS
ChemotherapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 26, 2026
SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study.

|Dec 22, 2023
Circulating small extracellular vesicles microRNAs plus CA-125 for treatment stratification in advanced ovarian cancer.

Xiaofang Zhou, Mu Liu, Lijuan Sun

|Sep 22, 2022
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study.

Jusheng An, Jie Tang, Benjamin X Li

|May 30, 2020
High expression of ESRP1 regulated by circ-0005585 promotes cell colonization in ovarian cancer.

Guanming Deng, Xiaofang Zhou, Le Chen

Pageof 1

Frequent Collaborators

1 joint publications

Jusheng An

1 joint publications

Benjamin X Li

1 joint publications

Huihua Xiong

1 joint publications

Hui Qiu